The Risks of "Healthy" E-Cigarettes: Unproven Claims & Lack of Regulation

Sep.07.2022
The Risks of "Healthy" E-Cigarettes: Unproven Claims & Lack of Regulation
Health e-cigarettes, containing vitamins, hormones or essential oils, are gaining popularity but often lack safety testing and evidence.

The so-called "healthy" electronic cigarettes are becoming increasingly popular. Unlike regular electronic cigarettes that contain nicotine, these products contain vitamins, hormones or essential oils. However, the US Food and Drug Administration (FDA) has taken notice because many companies that sell them have made unproven health claims.


Healthy electronic cigarettes, also known as "nutritional supplement diffusers," are a range of products found within electronic cigarettes. These devices deliver nicotine to the lungs without the need for combustion or tobacco, removing harmful compounds such as tobacco tar. Rather than burning, electronic cigarettes use the energy from a battery to heat up liquid and create a vapor that can be inhaled.


A new wave of products aims to use the same inhalation delivery system for various non-nicotine products, including vitamins (B12 and C being particularly popular), melatonin (a hormone), green tea, and various essential oils. The health e-cigarette company claims that different combinations of these additives can help you focus better, promote sleep, and even aid weight loss.


Inhaling, rather than swallowing, these compounds allows for faster absorption into the bloodstream, and therefore, in theory, vitamins and supplements can take effect more quickly when inhaled.


Many of these additives are familiar as supplements considered safe for consumption. However, most of them lack inhalation safety testing, particularly for potential long-term harm. Because health e-cigarettes are nicotine-free, they have avoided regulatory scrutiny.


The outbreak of 2019's electronic cigarette-related acute lung injury (Evali) in the United States highlighted the importance of detecting ingestion routes. Among the initially reported 60 fatal Evali cases, vitamin E acetate was identified as the key factor causing lung injury. As vitamin E is a common food additive, this makes it clear that even well-known substances can have severe health consequences when inhaled.


These devices are relatively new to the market, and therefore research on their safety is scarce. However, we can examine specific components to look for potential effects, both beneficial and harmful.


E-cigarette components


Many benign or beneficial compounds can become harmful if administered in an untested manner or to the wrong patient group. For example, the benefits of vitamin C are well-known, but it has been shown that high doses of vitamin C can increase the risk of death in sepsis patients.


Vitamin B12 is also a popular additive in these devices. B12 injections are highly effective in restoring vitamin levels for individuals who are deficient. However, there is no clear evidence to support any benefits for individuals with normal B12 levels. Additionally, we lack evidence regarding the safety or efficacy of inhaling B12.


A study conducted in 1967 showed that inhaling vitamin B12 had no benefits compared to injecting supplements. The researchers also noted the potential for lung damage in the same year.


We can also examine information regarding shared components with electronic cigarettes to search for potential impacts. Some products offer vitamin B12 dissolved in common e-liquid ingredient, vegetable glycerin. Other products use propylene glycol or a mixture of two liquids. When heated, these components can break down into harmful chemicals, such as formaldehyde.


These chemicals have been shown to damage alveolar macrophages, which are crucial immune cells in the lungs, in a way that does not depend on the presence of nicotine. Similar findings have also been observed in other important airway and immune cells.


The health e-cigarette that offers essential oils may also encounter similar issues. They contain a mixture of compounds called terpenes and other chemicals that are similar to e-liquids.


According to reports, terpenes have a range of benefits, including anti-cancer, anti-allergic, and antibacterial properties, which suggests potential benefits of using these essential oils. However, terpenes are thermally unstable and may decompose through inhalation into harmful compounds, which can irritate the respiratory system and potentially be toxic to cells at higher doses and prolonged exposure times.


Strengthening scrutiny" or "Intensifying scrutiny


Due to similarities between electronic cigarettes and "healthy" electronic cigarettes, these companies are currently facing increasingly strict scrutiny from public health institutions. The FDA has issued a warning stating that so-called healthy electronic cigarettes are "unsafe," "ineffective," and "unproven.


We must carefully weigh the benefits and risks of using these devices. Many of the supplements in these devices may help improve our lifestyle, but there is no evidence to support inhalation as being superior to traditional delivery methods.


The existence of healthy e-cigarettes has not been long enough for researchers to determine their long-term consequences. We know that short-term exposure to their components can damage the lungs, so long-term use could bring very serious risks - indicating that the scale of evidence is firmly against the use of "healthy e-cigarettes.


Statement:


This article is compiled from third-party information, provided only for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is intended solely for communication and research purposes within the industry.


Due to limitations in translation ability, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the stance and statements of the Chinese government on domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
The UK Parliament’s Parliamentary Office of Science and Technology (POST) has published a scientific briefing reviewing current evidence on the health effects of vape device components, including heating elements, power settings, metals, plastics, batteries and e-liquid ingredients, signalling growing regulatory attention to device design and whole-product systems beyond e-liquids, flavours and packaging.
Special Report
Jun.29
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations
News
Jun.26 by 2Firsts Perspectives
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
A U.S. appeals court ruled that British American Tobacco (BAT) must continue facing a consumer class action lawsuit over cigarette labels. The ruling allows the case to proceed but does not determine that BAT violated the law or is liable for damages. The case highlights ongoing legal risks facing major tobacco companies related to product labeling, consumer disclosures and product liability claims.
Jul.31
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Philip Morris International (PMI) has introduced VEEV inPrime, the next-generation closed-system vape platform featuring the new AdvanceVape Induction System™. Alongside the new induction platform, PMI has redesigned the pods, e-liquid formulations and user interaction experience. According to PMI and official IQOS websites, VEEV inPrime began a phased European rollout between May and June 2026, with products now available in Greece, Estonia, the United Kingdom and Italy.
Jul.14